Anti-inflammatory peptides and composition comprising same
US-2020208127-A1 · Jul 2, 2020 · US
Anti-inflammatory peptides and composition comprising the same
US11905536B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11905536-B2 |
| Application number | US-202117389671-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 30, 2021 |
| Priority date | Jul 20, 2012 |
| Publication date | Feb 20, 2024 |
| Grant date | Feb 20, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating or preventing inflammatory disease in a patient, comprising administering to the patient an isolated peptide having anti-inflammatory activity, wherein the peptide consists of the amino acid sequence of SEQ ID NO: 73 or SEQ ID NO: 130. 2. The method according to claim 1 , wherein the inflammatory disease is general or localized inflammatory disease; gastro-intestinal related diseases; dermal related diseases; vascular related disease; respiratory diseases; bone, joint, muscle, and connective tissue related diseases; urogenital disorders; central or peripheral nervous system related diseases; virus; or autoimmune diseases. 3. The method according to claim 1 , wherein the daily dose of the peptide is 0.1 μg/kg/day to 1 g/kg/day. 4. A method of treating or preventing skin inflammation comprising administering an isolated peptide having anti-inflammatory activity, wherein the peptide consists of the amino acid sequence of SEQ ID NO: 73 or SEQ ID NO: 130. 5. The method according to claim 4 , wherein the daily dose of the peptide is 0.1 μg/kg/day to 1 g/kg/day. 6. The method according to claim 2 , wherein the central or peripheral nervous system related disease is Alzheimer's disease; meningitis; encephalitis; multiple sclerosis; cerebral infarction; cerebral embolism; Guillain-Barre syndrome; neuritis; neuralgia; spinal cord injury; paralysis; or uveitis.
Assignees
Inventors
Classifications
- C12N9/1276Primary
RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase · CPC title
Peptides; Protein hydrolysates · CPC title
Transferases (2) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11905536B2 cover?
- The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprisi…
- Who is the assignee on this patent?
- Gemvax & Kael Co Ltd, Kim Sang Jae
- What technology area does this patent fall under?
- Primary CPC classification C12N9/1276. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).